To assess tumor control and quality of life (QOL) changes following stereotactic radiosurgery (SRS) for brain metastases using real-world data from a national registry, emphasizing the importance of this data in clinical decision-making.
Key Findings:
SRS demonstrated positive effects on preserving patients' pre-SRS functional capacity, with a notable percentage of patients reporting improvements.
Patients reported significant changes in QOL post-SRS, with improvements in EQ-5D scores averaging X points.
Local tumor control was achieved effectively with SRS compared to traditional therapies, with a control rate of Y%.
Interpretation:
The findings suggest that SRS not only aids in tumor control but also positively influences the quality of life for patients with brain metastases, highlighting its critical role in treatment decision-making and patient-centered care.
Limitations:
The study is observational and may be subject to selection bias, potentially affecting the generalizability of the findings.
Data on long-term QOL outcomes beyond the follow-up period were not captured, limiting insights into sustained benefits.
Conclusion:
Stereotactic radiosurgery is a beneficial treatment for brain metastases, improving both tumor control and quality of life, which should be considered in patient treatment plans, particularly regarding patient preferences and values.
